Akanda Corp. (AKAN)
NASDAQ: AKAN · Real-Time Price · USD
21.99
+0.08 (0.37%)
At close: May 29, 2026, 4:00 PM EDT
21.33
-0.66 (-3.00%)
After-hours: May 29, 2026, 6:08 PM EDT
Akanda Revenue
Akanda had revenue of $836.66K in the twelve months ending June 30, 2025, up 183.67% year-over-year. In the year 2024, Akanda had annual revenue of $836.66K with 97.47% growth.
Revenue (ttm)
$836.66K
Revenue Growth
+183.67%
P/S Ratio
13.71
Revenue / Employee
$18,188
Employees
46
Market Cap
11.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 836.66K | 412.98K | 97.47% |
| Dec 31, 2023 | 423.68K | -2.20M | -83.83% |
| Dec 31, 2022 | 2.62M | 2.58M | 6,223.00% |
| Dec 31, 2021 | 41.43K | 39.37K | 1,909.26% |
| Dec 31, 2020 | 2.06K | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aytu BioPharma | 56.60M |
| Biofrontera | 43.20M |
| Sunshine Biopharma | 35.49M |
| cbdMD | 19.98M |
| InMed Pharmaceuticals | 4.94M |
| TherapeuticsMD | 3.35M |
| China SXT Pharmaceuticals | 1.54M |
| RedHill Biopharma | 286.00K |
AKAN News
- 7 days ago - Akanda Corp. Announces Receipt of NASDAQ Noncompliance Letter - Newsfile Corp
- 7 days ago - Akanda Corp. Announces Cancellation of Special Meeting - Newsfile Corp
- 9 days ago - Akanda Corp trading resumes - TheFly
- 9 days ago - Akanda Corp trading halted, volatility trading pause - TheFly
- 22 days ago - Akanda Corp trading halted, volatility trading pause - TheFly
- 22 days ago - Akanda Corp trading resumes - TheFly
- 25 days ago - Akanda Corp trading resumes - TheFly
- 25 days ago - Akanda Corp trading halted, volatility trading pause - TheFly